Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 10/2000

01-10-2000

Streptococcal wall component OK432 restores sensitivity of non-obese diabetic (NOD) thymocytes to apoptotic signals

Authors: B. Decallonne, L. Overbergh, K. M. Casteels, C. Gysemans, R. Bouillon, C. Mathieu

Published in: Diabetologia | Issue 10/2000

Login to get access
Metadata
Title
Streptococcal wall component OK432 restores sensitivity of non-obese diabetic (NOD) thymocytes to apoptotic signals
Authors
B. Decallonne
L. Overbergh
K. M. Casteels
C. Gysemans
R. Bouillon
C. Mathieu
Publication date
01-10-2000
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 10/2000
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s001250051526

Other articles of this Issue 10/2000

Diabetologia 10/2000 Go to the issue

OriginalPaper

Temporal trends in incidence rates of Type I diabetes in Germany: calendar period rather than birth-cohort effects

OriginalPaper

MODY 2 presenting as neonatal hyperglycaemia: a need to reshape the definition of “neonatal diabetes”?

Review

Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease

OriginalPaper

Infections and risk of Type I (insulin-dependent) diabetes mellitus in Lithuanian children

OriginalPaper

Oral delivery of glucagon-like peptide-1 in a modified polymer preparation normalizes basal glycaemia in diabetic db/db mice

OriginalPaper

The World Health Organization International Collaborative Study for Islet Cell Antibodies

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits